Menu Close

Articles on side-effects

Displaying all articles

Lecanemab is an antibody that attaches to beta-amyloid proteins accumulated in the brain and allows the immune system to get rid of them. (Shutterstock)

Lecanemab: Experimental drug is a ray of hope for Alzheimer’s disease

An 18-month treatment with lecanemab slows functional and cognitive loss by 27 per cent in people with mild Alzheimer’s disease. But this is only the first step towards a real cure.
A healthcare worker holds up a vial of the AstraZeneca vaccine at a COVID-19 vaccination clinic in Montréal, on March 18. THE CANADIAN PRESS/Paul Chiasson 

Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms

Answers to key questions about rare blood clots linked to AstraZeneca’s COVID-19 vaccine, including risks, symptoms and whether people who have had one AstraZeneca shot should have a second.
Schizophrenia has been identified as a significant risk factor for dying of COVID-19. (Canva)

COVID-19 and schizophrenia: A potentially deadly combination

People with schizophrenia are almost three times more likely to die from COVID-19 than those without the serious mental illness, making it second only to age as a risk factor for mortality.

Top contributors

More